COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s): CSCI

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:CSCI - Post by User

COSCIENS Biopharma Inc > Cash

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Nov 19, 2024 5:52pm

24 Views

Post# 36320621

RE:RE:RE:RE:RE:RE:RE:RE:Cash

Tencents wrote: It is unlikely to see a forward business plan
Tge function of business planning , forecasting does not exist on the current Leadership Team

They've provided a net present value analysis previously for a 40 million dose immune booster plant.

<< Previous

Bullboard Posts

Next >>

Here are three global stocks you should watch